![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C12N 7/01 | |
C07K 14/00 | |||
C07H 21/00 | |||
A61K 39/12 | |||
C07K 14/08 |
(11) | Number of the document | 2324113 |
(13) | Kind of document | T |
(96) | European patent application number | 09805653.4 |
Date of filing the European patent application | 2009-08-10 | |
(97) | Date of publication of the European application | 2011-05-25 |
(45) | Date of publication and mention of the grant of the patent | 2018-02-28 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2009/053249 |
Date | 2009-08-10 |
(87) | Number | WO 2010/017542 |
Date | 2010-02-11 |
(30) | Number | Date | Country code |
87504 P | 2008-08-08 | US | |
218603 P | 2009-06-19 | US |
(72) |
RICHARDSON, Charles, US
BARGATZE, Robert, US
HAYNES, Joel, US
STEADMAN, Bryan, US
|
(73) |
Takeda Vaccines, Inc.,
75 Sidney Street, Cambridge, MA 02139,
US
|
(54) | VIRUS-LIKE PARTICLES COMPRISING COMPOSITE CAPSID AMINO ACID SEQUENCES FOR ENHANCED CROSS REACTIVITY |
VIRUS-LIKE PARTICLES COMPRISING COMPOSITE CAPSID AMINO ACID SEQUENCES FOR ENHANCED CROSS REACTIVITY |